Searched for
SUN PHARMA UPDATE
Markets rebound sharply: Sensex recovers 1,100 points from day’s low, Nifty closes near 23,650Sensex rose 1,100 points from its day’s low to close at 75,315, and Nifty 50 gained 333 points from its day’s low to end the session at 23,...- When the world's an oyster for Sun (Pharma)Indian companies are increasingly making bold acquisitions abroad. Sun Pharma's deal signals a new era of deliberate empire-building. This ...
- Stocks in news: RIL, IDFC First Bank, Paytm, Sun Pharma, Manappuram FinanceIndian markets faced pressure extending a corrective phase. Key companies like RIL, IDFC First Bank, and Paytm reported their financial res...
- Stock Market Crash Today: D-Street investors lose Rs 5 lakh crore. 7 reasons why Sensex and Nifty fellIndian stock markets experienced sharp losses for the third consecutive session, with Sensex and Nifty falling over 1% each. Escalating Ira...
- Why stock market rose today? Sensex jumps 500 points, Nifty settles above 24,350. 5 key factors explainedIndian stock markets saw significant gains on Friday. The Sensex and Nifty closed the week over 2% higher. This recovery follows a March se...
- Sun Pharma Q3 profit jumps 16% YoY as branded and innovative businesses drive growthSun Pharma announced strong third quarter results. Sales rose 15% to Rs 15,469 crore and net profit climbed 16% to Rs 3,368 crore. Growth w...
- Sun Pharma shares in focus after US FDA issues eight observations for Halol facilitySun Pharma shares will be in focus after the US FDA issued eight observations for its Halol facility following a GMP inspection. The plant ...
- Sun Pharma announces Rs 10.50/share interim dividend, sets Feb 6 as record dateThe company set February 6, 2025, as the record date for the dividend, payable by February 20, 2025. The company announced the dividend alo...
- Stock Radar: 60% rally in a year! This pharma stock is likely to continue its winning runSun Pharma's stock price has surged over 60% in the past year, hitting a record high of Rs 1,960 on September 30th. Though profit-taking ha...
- Sun Pharma Q4 Results: Profit jumps 34% YoY to Rs 2,654 crore, meets Street estimatesSun Pharma Q4 Results: The company's revenue rose 10% year-on-year to Rs 11,983 crore in the reporting quarter. It was Rs 10,931 crore a ye...
- Sun Pharma Q3 Results: Net profit jumps 15.5% to Rs 2524 croreSun Pharma on Wednesday reported a 16.5% year-on-year (YoY) jump in net profit to Rs 2524 crore in Q3FY24 led by broad-based growth, includ...
- Sun Pharma to acquire US-based Concert for $576 millionConcert's lead candidate, deuruxolitinib, is being evaluated as a treatment for autoimmune condition alopecia areata, which results in patc...
- Sun Pharma Q3 Results Preview: Net profit may fall 7%; sales seen rising 8-9%Net sales for the pharma major is seen rising 9.04 per cent YoY to Rs 9,635 crore from Rs 8,836 crore in the same quarter last year. Ebitda...
- Sebi seeks answers on Sun Pharma’s two issuesA whistle-blower complaint has alleged that the company reportedly dealt with banned traders.
- Sun Pharma: Too little, too late?In total, Rs 10,665 crore of investor wealth has been lost between the two investor updates.
- Sun Pharma’s update may not be enough to allay investor concernsThe stock is now one-third of its record high value reached three years ago.
- Sun Pharma’s profit warning may not go down well with the StreetIt implies that the Ranbaxy integration along with the remediation process of US FDA compliance issue at the Sun’s Halol plant has started ...
- Sun Pharmaceutical, Merck & Co call off 2011 JV: SourcesSun Pharma & US-based Merck & Co have called off their more than three-year-old joint venture that aimed to bring innovative drugs to emerg...
- Sun Pharma’s Outperformance likely to continue on a strong March QuarterIts export business, dominated by revenues from the US, is likely to post a revenue increase of around 45 per cent driven by factors like t...
- Sun may hike offer for Taro stakeSun Pharmaceutical Industries, which has been struggling over the last few months to gain control over Israel’s Taro Pharmaceutical Industr...
Load More
